Lurasidone Dose Escalation in Early Nonresponding Patients With Schizophrenia: A Randomized, Placebo-Controlled Study

Loebel Antony; Silva Robert; Goldman Robert; Watabe Kei; Cucchiaro Josephine; Citrome Leslie; Kane John M.

首页> 外文期刊>The journal of clinical psychiatry >Lurasidone Dose Escalation in Early Nonresponding Patients With Schizophrenia: A Randomized, Placebo-Controlled Study

【24h】

Lurasidone Dose Escalation in Early Nonresponding Patients With Schizophrenia: A Randomized, Placebo-Controlled Study

机译：早期无反应性精神分裂症患者的卢拉西酮剂量升高：一项随机，安慰剂对照的研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective: To assess the effect of dose increase in adult patients with schizophrenia who demonstrate inadequate initial response to standard-dose lurasidone and to evaluate the efficacy of low-dose lurasidone in adult patients with schizophrenia.

机译：目的：评估剂量增加对成人对标准剂量卢拉西酮的初始反应不足的精神分裂症患者的疗效，并评估低剂量卢拉西酮在成人精神分裂症患者中的疗效。

著录项

来源
《The journal of clinical psychiatry》 |2016年第12期|共15页
作者
Loebel Antony; Silva Robert; Goldman Robert; Watabe Kei; Cucchiaro Josephine; Citrome Leslie; Kane John M.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类精神病学;
关键词

相似文献

外文文献
中文文献
专利

1. Lurasidone Dose Escalation in Early Nonresponding Patients With Schizophrenia: A Randomized, Placebo-Controlled Study [J] . Antony Loebel, John M. Kane, Josephine Cucchiaro, Primary care companion to the journal of clinical psychiatry . 2016,第12期

机译：早期无反应性精神分裂症患者的卢拉西酮剂量升高：一项随机，安慰剂对照的研究
2. A double-blind, placebo-controlled, randomized withdrawal study of lurasidone for the maintenance of efficacy in patients with schizophrenia [J] . Tandon Rajiv, Cucchiaro Josephine, Phillips Debra, Journal of psychopharmacology . 2016,第1期

机译：卢拉西酮对精神分裂症患者维持疗效的双盲，安慰剂对照，随机戒断研究
3. Lurasidone for the treatment of acutely psychotic patients with schizophrenia: A 6-week, randomized, placebo-controlled study [J] . NasrallahH.A., SilvaR., PhillipsD., Journal of psychiatric research . 2013,第5期

机译：卢拉西酮治疗急性精神病性精神分裂症的患者：一项为期六周的随机安慰剂对照研究
4. A Randomized, Placebo-Controlled Study of the Efficacy of Cognitive Intervention on Elderly People and on Patient's with Alzheimer's Disease [C] . J.J. Yanguas, C. Buiza, I. Etxeberria, International Conference on Computers Helping People with Special Needs(ICCHP 2006); 20060711-13; Linz(AT) . 2006

机译：认知干预对老年人和阿尔茨海默氏病患者疗效的随机，安慰剂对照研究
5. A phase I study of vincristine, escalating doses of irinotecan, temozolomide and bevacizumab (VIT-B) in pediatric and adolescent patients with recurrent or refractory solid tumors of non-hematopoietic origin [D] . Venkatramani, Rajkumar. 2010

机译：长春新碱，伊非替康，替莫唑胺和贝伐单抗（VIT-B）逐步剂量在患有非造血源性复发或难治性实体瘤的儿童和青少年患者中的I期研究
6. A double-blind placebo-controlled randomized withdrawal study of lurasidone for the maintenance of efficacy in patients with schizophrenia [O] . Rajiv Tandon, Josephine Cucchiaro, Debra Phillips, -1

机译：卢拉西酮维持精神分裂症患者疗效的双盲安慰剂对照随机退出研究
7. A double-blind, placebo-controlled, randomized withdrawal study of lurasidone for the maintenance of efficacy in patients with schizophrenia [O] . Rajiv Tandon, Josephine Cucchiaro, Debra Phillips, 2015

机译：一种双盲，安慰剂对照，随机戒断研究，用于维持精神分裂症患者疗效的疗效

Lurasidone Dose Escalation in Early Nonresponding Patients With Schizophrenia: A Randomized, Placebo-Controlled Study

摘要

著录项

相似文献

相关主题

期刊订阅